Synthesis and antimicrobial properties of imidazolium and pyrrolidinonium salts. 2004

D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology, 373-1 Guseong-dong, Yuseong-gu, Daejeon 305-701, South Korea.

For the purpose of developing new disinfectants and antiseptics, we searched for compounds having high bactericidal activity against gram-positive bacteria, gram-negative bacteria, and fungi. Three different series of quaternary imidazolium and pyrrolidinonium salts were synthesized: series A (1-alkyl-3-methylimidazolium chlorides and bromides); series B (1-alkyl-2-methyl-3-hydroxyethylimidazolium chlorides); and series C (N-alkyl-N-hydroxyethylpyrrolidinonium). Series B and C were newly designed. These three series were tested to evaluate their antibacterial and antifungal properties for the first time. Seven microbial strains were used in the study: Escherichia coli KCTC1924, Salmonella typhimurium KCTC1926, Staphylococcus aureus 209 KCTC1916, Staphylococcus aureus R209 KCTC1928, Bacillus subtilis KCTC1914, Candida albicans KCTC1940, and Chlorella regularis. The antimicrobial efficiency was measured by bacterial and fungal growth inhibition expressed as minimal inhibitory concentration (MIC) values. Series A and B imidazolium salts had very good antimicrobial activity against the examined Gram-negative bacteria, Gram-positive bacteria, and fungi. Also the pyrrolidinonium salt was found to have low MIC for some of tested microorganisms. The antibacterial and antifungal active properties of the salts depend upon the structure of functional groups and the alkyl chain length in the imidazolium and pyrrolidinonium ring. Among the synthesized quaternary imidazolium and pyrrolidinonium salts, the imidazolium salts containing a long alkyl chain and the introduction of a hydroxyethyl chain and methyl group into the imidazolium ring structure leads to broad spectrum active antimicrobial agents which not only have bacteriostatic properties but could be powerful bactericides.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D003904 Mitosporic Fungi A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group. Deuteromycetes,Deuteromycota,Fungi imperfecti,Fungi, Mitosporic,Hyphomycetes,Deuteromycete,Deuteromycotas,Fungi imperfectus,Fungus, Mitosporic,Hyphomycete,Mitosporic Fungus,imperfectus, Fungi
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012492 Salts Substances produced from the reaction between acids and bases; compounds consisting of a metal (positive) and nonmetal (negative) radical. (Grant & Hackh's Chemical Dictionary, 5th ed) Salt
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
May 2019, The Journal of steroid biochemistry and molecular biology,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
March 2021, Bioorganic chemistry,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
March 2014, European journal of medicinal chemistry,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
December 2022, Archiv der Pharmazie,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
September 2020, Molecules (Basel, Switzerland),
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
March 2022, Dalton transactions (Cambridge, England : 2003),
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
April 2020, Inorganic chemistry,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
July 2020, Bioorganic & medicinal chemistry letters,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
November 2018, RSC advances,
D Demberelnyamba, and Ki-Sub Kim, and Sukjeong Choi, and Seung-Yeob Park, and Huen Lee, and Chang-Jin Kim, and Ick-Dong Yoo
April 2023, Dalton transactions (Cambridge, England : 2003),
Copied contents to your clipboard!